These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16543027)

  • 1. Cost and value: everything or nothing?
    Mackie P; Sim F
    Public Health; 2006 Apr; 120(4):281-2. PubMed ID: 16543027
    [No Abstract]   [Full Text] [Related]  

  • 2. The acceptability of acceptability curves: comments on Groot Koerkamp and others.
    Schwartz A
    Med Decis Making; 2007; 27(2):96-7. PubMed ID: 17409359
    [No Abstract]   [Full Text] [Related]  

  • 3. Tracking the Impact of Policy Changes on Public Health Practice.
    Erwin PC;
    Am J Public Health; 2017 May; 107(5):653-654. PubMed ID: 28398785
    [No Abstract]   [Full Text] [Related]  

  • 4. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emotions and decision rules in discrete choice experiments for valuing health care programmes for the elderly.
    Araña JE; León CJ; Hanemann MW
    J Health Econ; 2008 May; 27(3):753-69. PubMed ID: 18241944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
    Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
    Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conclusion: where next?
    Martin R; Coker R
    Public Health; 2006 Oct; 120 Suppl():81-7. PubMed ID: 16979195
    [No Abstract]   [Full Text] [Related]  

  • 8. Why is it difficult to evaluate the effectiveness and cost-effectiveness of complex public health interventions in the community? A health economics perspective.
    Perspect Public Health; 2017 Jul; 137(4):206-207. PubMed ID: 28675333
    [No Abstract]   [Full Text] [Related]  

  • 9. Measurement of costs.
    Riewpaiboon A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S28-37. PubMed ID: 19253485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Econometric modeling of health care costs and expenditures: a survey of analytical issues and related policy considerations.
    Mullahy J
    Med Care; 2009 Jul; 47(7 Suppl 1):S104-8. PubMed ID: 19536020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 12. Dispelling the fog of myth.
    Thayer FC
    Adm Radiol; 1992 May; 11(5):13-5. PubMed ID: 10119290
    [No Abstract]   [Full Text] [Related]  

  • 13. Will the right to the protection of health be a real one in the future European Union?
    Reverte-Cejudo D; Sanchez-Bayle M
    J Epidemiol Community Health; 2005 Mar; 59(3):181. PubMed ID: 15709074
    [No Abstract]   [Full Text] [Related]  

  • 14. From epidemiology to policy: toward more effective practice.
    Brownson RC; Hartge P; Samet JM; Ness RB
    Ann Epidemiol; 2010 Jun; 20(6):409-11. PubMed ID: 20470966
    [No Abstract]   [Full Text] [Related]  

  • 15. Sur model with spatial effects: an application to mental health expenditure.
    Moscone F; Tosetti E; Knapp M
    Health Econ; 2007 Dec; 16(12):1403-8. PubMed ID: 17351884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health utility and economic analysis: theoretical and practical issues.
    Payakachat N; Murawski MM; Summers KH
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):289-92. PubMed ID: 19670986
    [No Abstract]   [Full Text] [Related]  

  • 17. Balancing equity and efficiency in health priorities in Ghana: the use of multicriteria decision analysis.
    Jehu-Appiah C; Baltussen R; Acquah C; Aikins M; d'Almeida SA; Bosu WK; Koolman X; Lauer J; Osei D; Adjei S
    Value Health; 2008 Dec; 11(7):1081-7. PubMed ID: 19602214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care technology adoption and diffusion in a social context.
    Coyte PC; Holmes D
    Policy Polit Nurs Pract; 2007 Feb; 8(1):47-54. PubMed ID: 17470771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation of economic evaluation results.
    Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S66-73. PubMed ID: 19253489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discounting in economic evaluations: stepping forward towards optimal decision rules.
    Gravelle H; Brouwer W; Niessen L; Postma M; Rutten F
    Health Econ; 2007 Mar; 16(3):307-17. PubMed ID: 17006970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.